Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02681679Completed
Randomised, double-blind trial in cataract comparing 0.1% bromfenac with Placebo (2 arms). Primary endpoints: Pupil area measured using ImageJ software A and Prostaglandin E2 levels. Started Oct 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02681679.